Site is Being Upgraded

Lifespan extension therapy: Atorvastatin (Trade name: Lipitor), a lipid-lowering agent, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 10/January/2017, 6.38 pm,

Vitamin-based Combinatorial therapy for reversing TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Sulforaphane (PMSFN) augments the expression of FGF19 and FGF1,   attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIIDM via up regulation of its target gene, 10/January/2017, 6.24 pm
January 10, 2018
Molecular therapy for Metastatic cancers: Torasemide, an anti-hypertensive drug, increases the expression of tumor suppressors PDCD4 and PTEN, inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up regulation of its target gene, 10/January/2017, 6.52 pm
January 10, 2018
Show all

Significance of the study:

It has been shown earlier that antagonizing angiotensin II type I receptor (AT1R) expression may prolong mammalian life span. Further, it has been shown that disruption of AT1R (AGTR1) gene results in marked prolongation of mammalian lifespan. 


From research findings to therapeutic opportunity: 

This study suggests, for the first time, that Atorvastatin, by increasing the expression of its target genes,  it may decrease the expression of AT1R.

Figure1. Mechanistic insights into how the lipid-lowering agent Atorvastatin functions as a longevity-promoter. Atorvastatin, by increasing the expression of its downstream target genes, down regulates A1TR expression and promotes longevity.

Figure 2. The chemical structure of Atorvastatin. Atorvastatin may decrease blood pressure, inhibit insulin resistance and attenuate cardiac ageing.

 

And, thereby, it may: (1) decrease blood pressure; (2) decrease blood sugar levels; (3) inhibit pulmonary fibrosis; (4) enhance bacterial immunity; (5) inhibit myocardial infarction; (6) decelerate ageing process; and (4) extend the lifespan of an individual. Thus, pharmacological formulations encompassing “Atorvastatin or its analogues, either alone or in combination with other anti-ageing/longevity promoting compounds,” may be used to extend the lifespan of an individual (Figures 1-2).

Price 300[easy_payment currency=”USD”]


Details of the research findings: 

Idea Proposed/Formulated by:

Dr L Boominathan Ph.D.  

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How  does Atorvastatin suppress the expression of  angiotensin II type I receptor (AT1R)? 

Amount: $300#

For purchase and payment details, you may reach us at info@genomediscovery.org

#  Research cooperation


References: 

CitationBoominathan, L., Lifespan extension therapy: Atorvastatin (Trade name: Lipitor), a lipid-lowering agent, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 10/January/2017, 6.38 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.